Consainsights logo
Reports > Life Sciences > Self Monitoring Blood Glucose Market Report

Self Monitoring Blood Glucose Market Size, Share, Industry Trends and Forecast to 2033

This report delves into the Self Monitoring Blood Glucose market, providing insights into market dynamics, size assessments, future trends, and competitive landscape from 2023 to 2033.

Metric Value
Study Period 2023 - 2033
2023 Market Size $4.50 Billion
CAGR (2023-2033) 6.8%
2033 Market Size $8.84 Billion
Top Companies Abbott Laboratories, Roche Diagnostics, Medtronic, Johnson & Johnson
Last Modified Date 15 Nov 2024

Self Monitoring Blood Glucose Market Report (2023 - 2033)

Self Monitoring Blood Glucose Market Overview

The Self Monitoring Blood Glucose industry has been continuously evolving, driven primarily by technological innovations and increasing consumer awareness of diabetes management. Key trends include the integration of smartphone applications with glucose meters and the rise of connected devices, enabling real-time monitoring and data sharing with healthcare providers. The COVID-19 pandemic has also emphasized the need for remote monitoring solutions, further spurring innovation. Regulatory frameworks are becoming stricter, emphasizing safety, accuracy, and performance of diabetes management products, which shapes market dynamics significantly.

What is the Market Size & CAGR of Self Monitoring Blood Glucose market in 2023?

In 2023, the global Self Monitoring Blood Glucose market is estimated to be valued at $4.93 billion. The market is projected to witness a compound annual growth rate (CAGR) of 7.38% from 2023 to 2033, potentially reaching approximately $10.18 billion by 2033. This growth is attributed to the increasing diabetes prevalence, expanding global awareness regarding diabetes management, and technological advancements in blood glucose monitoring devices.

Self Monitoring Blood Glucose Industry Analysis

The Self Monitoring Blood Glucose industry has been continuously evolving, driven primarily by technological innovations and increasing consumer awareness of diabetes management. Key trends include the integration of smartphone applications with glucose meters and the rise of connected devices, enabling real-time monitoring and data sharing with healthcare providers. The COVID-19 pandemic has also emphasized the need for remote monitoring solutions, further spurring innovation. Regulatory frameworks are becoming stricter, emphasizing safety, accuracy, and performance of diabetes management products, which shapes market dynamics significantly.

Self Monitoring Blood Glucose Market Segmentation and Scope

The Self Monitoring Blood Glucose market is segmented based on product type, technology, end-user, and distribution channel. Product segmentation includes glucose meters, test strips, and lancing devices. The technology segment is divided into invasive and non-invasive technologies, while end-user segmentation distinguishes between individuals and healthcare facilities. Distribution channels are further divided into online and offline segments. Each segment holds significant importance in catering to diverse consumer needs and preferences in diabetes management.

Request a custom research report for industry.

Self Monitoring Blood Glucose Market Analysis Report by Region

Europe Self Monitoring Blood Glucose Market Report:

In Europe, the market stands at $1.41 billion in 2023, anticipated to nearly double to $2.77 billion by 2033. Factors such as high levels of diabetes awareness, strong healthcare systems, and technological advancements contribute to this growth.

Asia Pacific Self Monitoring Blood Glucose Market Report:

The Asia Pacific region represents a burgeoning market for Self Monitoring Blood Glucose devices, estimated at $0.83 billion in 2023, expected to grow to $1.64 billion by 2033. Factors driving this growth include a rising population of diabetic patients and increased healthcare spending, alongside growing awareness of SMBG among patients and healthcare providers.

North America Self Monitoring Blood Glucose Market Report:

The North American Self Monitoring Blood Glucose market is one of the largest, valued at $1.66 billion in 2023 and expected to see significant growth to $3.27 billion by 2033. This region benefits from advanced healthcare systems, high rates of diabetes, and a growing trend towards personal health management technologies.

South America Self Monitoring Blood Glucose Market Report:

In South America, the SMBG market is estimated to be valued at $0.16 billion in 2023, with projections reaching $0.32 billion by 2033. The growth is predicated on increasing diabetes prevalence, improving healthcare infrastructure, and an emphasis on patient education and self-management strategies.

Middle East & Africa Self Monitoring Blood Glucose Market Report:

The market in the Middle East and Africa is valued at $0.43 billion in 2023 and is expected to grow to $0.85 billion by 2033. This expansion is driven by a rising diabetic population, increasing healthcare investments, and a greater focus on preventive healthcare measures.

Request a custom research report for industry.

Self Monitoring Blood Glucose Market Analysis By Product

Global Self-Monitoring Blood Glucose Market, By Product Market Analysis (2023 - 2033)

The product segments of the SMBG market show significant financial performance. Glucose Meters dominate this segment, with market sizes expected to rise from $2.79 billion in 2023 to $5.47 billion by 2033 (61.9% market share). Test strips also show robust growth with size estimates moving from $1.16 billion to $2.27 billion (25.72% share), while lancing devices account for $0.56 billion, projected to reach $1.09 billion (12.38% share) in the same period.

Self Monitoring Blood Glucose Market Analysis By Technology

Global Self-Monitoring Blood Glucose Market, By Technology Market Analysis (2023 - 2033)

The SMBG market is categorized into invasive and non-invasive technologies. The invasive technology segment holds a massive market size of $3.86 billion in 2023, poised to double to $7.58 billion by 2033, thereby retaining an 85.72% market share. Meanwhile, non-invasive technology is gradually gaining traction, moving from $0.64 billion to $1.26 billion, holding a 14.28% market share.

Self Monitoring Blood Glucose Market Analysis By End User

Global Self-Monitoring Blood Glucose Market, By End-User Market Analysis (2023 - 2033)

The end-user segment primarily consists of individuals, which dominate the market with a size of $3.86 billion in 2023, expected to increase to $7.58 billion by 2033 (85.72% share). Healthcare facilities, though smaller, are projected to grow from $0.64 billion to $1.26 billion, maintaining a 14.28% market share.

Self Monitoring Blood Glucose Market Analysis By Distribution Channel

Global Self-Monitoring Blood Glucose Market, By Distribution Channel Market Analysis (2023 - 2033)

E-commerce plays a crucial role in the SMBG market, holding a substantial market size of $3.86 billion in 2023 and forecasted to rise to $7.58 billion by 2033 (85.72% share). Offline channels are also relevant but smaller, forecasted to grow from $0.64 billion to $1.26 billion, capturing a 14.28% market share.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Self Monitoring Blood Glucose Industry

Abbott Laboratories:

Abbott is at the forefront of diabetes care technology, offering innovative glucose monitoring systems that empower patients with real-time data, such as the FreeStyle Libre.

Roche Diagnostics:

Roche provides a comprehensive range of SMBG devices and plays a pivotal role in advancing diabetes monitoring with products like the Accu-Chek series.

Medtronic:

Medtronic is a leader in medical technology and offers various diabetes care solutions, including insulin delivery systems and advanced blood glucose monitoring.

Johnson & Johnson:

Through its LifeScan segment, Johnson & Johnson offers the OneTouch brand, which is a widely recognized name in blood glucose monitoring.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs